4//SEC Filing
Lennon David James 4
Accession 0001415889-25-006316
CIK 0001422142other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:37 PM ET
Size
9.4 KB
Accession
0001415889-25-006316
Insider Transaction Report
Form 4
Lennon David James
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-03-01+16,250→ 39,119 total - Exercise/Conversion
Restricted Stock Units
2025-03-01−16,250→ 48,750 total→ Common Stock (16,250 underlying) - Sale
Common Stock
2025-03-03$2.35/sh−5,690$13,372→ 33,429 total
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock.
- [F2]Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
- [F3]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean March 1, 2024.
Documents
Issuer
Aadi Bioscience, Inc.
CIK 0001422142
Entity typeother
Related Parties
1- filerCIK 0001995275
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 8:37 PM ET
- Size
- 9.4 KB